Skip to main content

Advertisement

Log in

Re: Letter to editor: heart rate effects of antimuscarinic drugs

  • Response – Urology Letter
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cetinel B, Onal B, Gultekin MH, Guzelsoy M, Turegun FA, Dincer M (2019) Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial. Int Urol Nephrol 51(3):417–424

    Article  CAS  Google Scholar 

  2. Severinghaus JW (2007) Takuo Aoyagi: discovery of pulse oximetry. Anesth Analg 105(6 Suppl):S1–S4

    Article  Google Scholar 

  3. Yetkin U, Karahan N, Gürbüz A (2002) Klinik Uygulamada Pulse Oksimetre. Van Tıp Dergisi 9(4):126–133 (Article in Turkish)

    Google Scholar 

  4. Ristikankare M, Karinen-Mantila H (2016) The role of routinely given hyoscine-N-butylbromide in colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial. Scand J Gastroenterol 51(3):368–373

    Article  CAS  Google Scholar 

  5. Kossmann CE (1953) The normal electrocardiogram. Circulation 8:920–936

    Article  CAS  Google Scholar 

  6. Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS (2010) Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int 106(2):268–274

    Article  Google Scholar 

  7. Rothman KJ (2010) Curbing type I and type II errors. Eur J Epidemiol 25(4):223–224

    Article  Google Scholar 

  8. Tadic M, Cuspidi C, Grassi G (2018) Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest 48:e12892

    Article  Google Scholar 

  9. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Authors/Task Force Members; Document Reviewers et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975

    Article  Google Scholar 

  10. Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE (2012) Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting. BJU Int 109(4):572–580

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Hamza Gultekin.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cetinel, B., Onal, B. & Gultekin, M.H. Re: Letter to editor: heart rate effects of antimuscarinic drugs. Int Urol Nephrol 51, 1785–1786 (2019). https://doi.org/10.1007/s11255-019-02240-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-019-02240-z

Navigation